

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.39422360 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.08087354 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.08087354 |
| 4 | negative regulation of cell size (GO:0045792) | 4.94043319 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.71937075 |
| 6 | mannose metabolic process (GO:0006013) | 4.71584302 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.58606479 |
| 8 | creatine metabolic process (GO:0006600) | 4.50578448 |
| 9 | regulation of gamma-delta T cell activation (GO:0046643) | 4.13919148 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.89268298 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.81916000 |
| 12 | negative thymic T cell selection (GO:0045060) | 3.75434690 |
| 13 | histone H4 deacetylation (GO:0070933) | 3.74819583 |
| 14 | thymic T cell selection (GO:0045061) | 3.63051822 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.58777468 |
| 16 | negative T cell selection (GO:0043383) | 3.51037150 |
| 17 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.49600407 |
| 18 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.49600407 |
| 19 | histone H3 deacetylation (GO:0070932) | 3.42277461 |
| 20 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.41105322 |
| 21 | positive thymic T cell selection (GO:0045059) | 3.36878609 |
| 22 | negative regulation of necroptotic process (GO:0060546) | 3.33358807 |
| 23 | regulation of granulocyte differentiation (GO:0030852) | 3.28258919 |
| 24 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.26311341 |
| 25 | positive regulation of granulocyte differentiation (GO:0030854) | 3.25946325 |
| 26 | germinal center formation (GO:0002467) | 3.20256693 |
| 27 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.20177909 |
| 28 | Peyers patch development (GO:0048541) | 3.15334263 |
| 29 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.15334263 |
| 30 | T cell selection (GO:0045058) | 3.14654787 |
| 31 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.13842846 |
| 32 | negative regulation of granulocyte differentiation (GO:0030853) | 3.12709955 |
| 33 | regulation of cholesterol metabolic process (GO:0090181) | 3.05004627 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.01633499 |
| 35 | tricarboxylic acid metabolic process (GO:0072350) | 3.01573317 |
| 36 | regulation of ARF GTPase activity (GO:0032312) | 2.95216249 |
| 37 | retinoic acid receptor signaling pathway (GO:0048384) | 2.94926943 |
| 38 | amyloid precursor protein catabolic process (GO:0042987) | 2.92401160 |
| 39 | regulation of necroptotic process (GO:0060544) | 2.91596232 |
| 40 | cellular response to interleukin-4 (GO:0071353) | 2.89903168 |
| 41 | muscle filament sliding (GO:0030049) | 2.89699047 |
| 42 | actin-myosin filament sliding (GO:0033275) | 2.89699047 |
| 43 | negative regulation of innate immune response (GO:0045824) | 2.88134396 |
| 44 | 2-oxoglutarate metabolic process (GO:0006103) | 2.87603023 |
| 45 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.84149124 |
| 46 | B cell receptor signaling pathway (GO:0050853) | 2.83625206 |
| 47 | negative regulation of necrotic cell death (GO:0060547) | 2.82426975 |
| 48 | response to muramyl dipeptide (GO:0032495) | 2.81410687 |
| 49 | histone H4-K8 acetylation (GO:0043982) | 2.80511895 |
| 50 | histone H4-K5 acetylation (GO:0043981) | 2.80511895 |
| 51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.79222747 |
| 52 | histone H4-K16 acetylation (GO:0043984) | 2.74396196 |
| 53 | detection of bacterium (GO:0016045) | 2.73794512 |
| 54 | NIK/NF-kappaB signaling (GO:0038061) | 2.73212255 |
| 55 | NADH metabolic process (GO:0006734) | 2.72710356 |
| 56 | response to interleukin-4 (GO:0070670) | 2.72597782 |
| 57 | modulation by virus of host process (GO:0019054) | 2.69449640 |
| 58 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.68610150 |
| 59 | histone H3-K9 demethylation (GO:0033169) | 2.64564167 |
| 60 | positive regulation of B cell differentiation (GO:0045579) | 2.64104116 |
| 61 | cellular hyperosmotic response (GO:0071474) | 2.63407468 |
| 62 | regulation of necrotic cell death (GO:0010939) | 2.59495280 |
| 63 | negative regulation of myotube differentiation (GO:0010832) | 2.58051628 |
| 64 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.55311013 |
| 65 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.54950400 |
| 66 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.54257121 |
| 67 | glycogen catabolic process (GO:0005980) | 2.52418322 |
| 68 | positive T cell selection (GO:0043368) | 2.49072440 |
| 69 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.48440421 |
| 70 | detection of other organism (GO:0098543) | 2.47951491 |
| 71 | pinocytosis (GO:0006907) | 2.46551123 |
| 72 | skeletal muscle contraction (GO:0003009) | 2.45889440 |
| 73 | amyloid precursor protein metabolic process (GO:0042982) | 2.45113725 |
| 74 | positive regulation of histone deacetylation (GO:0031065) | 2.43684345 |
| 75 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.42913443 |
| 76 | barbed-end actin filament capping (GO:0051016) | 2.42409758 |
| 77 | dosage compensation (GO:0007549) | 2.42132865 |
| 78 | response to laminar fluid shear stress (GO:0034616) | 2.42076754 |
| 79 | histone H4-K12 acetylation (GO:0043983) | 2.42042357 |
| 80 | regulation of monocyte differentiation (GO:0045655) | 2.40263891 |
| 81 | proline biosynthetic process (GO:0006561) | 2.39399962 |
| 82 | positive regulation of myotube differentiation (GO:0010831) | 2.39234717 |
| 83 | regulation of histone H3-K27 methylation (GO:0061085) | 2.38991784 |
| 84 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.38802222 |
| 85 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.36998785 |
| 86 | mature B cell differentiation involved in immune response (GO:0002313) | 2.36598719 |
| 87 | leukocyte aggregation (GO:0070486) | 2.35770836 |
| 88 | regulation of ARF protein signal transduction (GO:0032012) | 2.35602846 |
| 89 | glucan catabolic process (GO:0009251) | 2.35171929 |
| 90 | galactose catabolic process (GO:0019388) | 2.34790153 |
| 91 | purine nucleotide salvage (GO:0032261) | 2.34341559 |
| 92 | snRNA metabolic process (GO:0016073) | 2.33596263 |
| 93 | cardiolipin metabolic process (GO:0032048) | 2.32977755 |
| 94 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.31832236 |
| 95 | pentose-phosphate shunt (GO:0006098) | 2.31755478 |
| 96 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.31639998 |
| 97 | peptidyl-lysine dimethylation (GO:0018027) | 2.31492772 |
| 98 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.31391014 |
| 99 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.31355905 |
| 100 | retrograde transport, endosome to Golgi (GO:0042147) | 2.30736661 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.28084574 |
| 2 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.12605042 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 2.99037257 |
| 4 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.58308466 |
| 5 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.42934673 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.39271022 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.38004987 |
| 8 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.28198124 |
| 9 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.15020906 |
| 10 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.14246006 |
| 11 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.09453451 |
| 12 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.05519186 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.00970672 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.00092917 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.96129217 |
| 16 | P68_20966046_ChIP-Seq_HELA_Human | 1.92011411 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 1.89696757 |
| 18 | MAF_26560356_Chip-Seq_TH2_Human | 1.86961549 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83118875 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.82787923 |
| 21 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.79230439 |
| 22 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.78549647 |
| 23 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.78498156 |
| 24 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.74269093 |
| 25 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.72721130 |
| 26 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70919220 |
| 27 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.69856275 |
| 28 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.69126249 |
| 29 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.67773647 |
| 30 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.67007831 |
| 31 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.64011399 |
| 32 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.63977976 |
| 33 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.62703000 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.60523359 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59340671 |
| 36 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.59075774 |
| 37 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.58376352 |
| 38 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.56365268 |
| 39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.56330213 |
| 40 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.54457677 |
| 41 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.54310433 |
| 42 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.48219605 |
| 43 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.47102906 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46609016 |
| 45 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.44990677 |
| 46 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.43713116 |
| 47 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43404349 |
| 48 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.42153989 |
| 49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40679470 |
| 50 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.39199802 |
| 51 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.38735461 |
| 52 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.36311522 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.35948895 |
| 54 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.35407371 |
| 55 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.34691372 |
| 56 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.34416367 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.33577416 |
| 58 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31328742 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31164814 |
| 60 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30799981 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27500238 |
| 62 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26648288 |
| 63 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.26630564 |
| 64 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.26152818 |
| 65 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.25929394 |
| 66 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.24657579 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24534158 |
| 68 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23428683 |
| 69 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.22377722 |
| 70 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.21789073 |
| 71 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20907964 |
| 72 | MYB_26560356_Chip-Seq_TH1_Human | 1.19190697 |
| 73 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.18446562 |
| 74 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17759786 |
| 75 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.17369801 |
| 76 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.17340880 |
| 77 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.16451933 |
| 78 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.15814197 |
| 79 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.15713055 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15334802 |
| 81 | MYB_26560356_Chip-Seq_TH2_Human | 1.15253553 |
| 82 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.14833077 |
| 83 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14069655 |
| 84 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13837419 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13808875 |
| 86 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.13664042 |
| 87 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.12891475 |
| 88 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11912359 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09221941 |
| 90 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08134314 |
| 91 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07876745 |
| 92 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07499423 |
| 93 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.06913565 |
| 94 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06717535 |
| 95 | SA1_27219007_Chip-Seq_Bcells_Human | 1.05987690 |
| 96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05385204 |
| 97 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04170297 |
| 98 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03968270 |
| 99 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.03696118 |
| 100 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03587146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.75710937 |
| 2 | MP0000751_myopathy | 3.36825830 |
| 3 | MP0008260_abnormal_autophagy | 3.25200006 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 3.03901970 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.82034809 |
| 6 | MP0009278_abnormal_bone_marrow | 2.73058723 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.70715448 |
| 8 | MP0003436_decreased_susceptibility_to | 2.67177923 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.47025983 |
| 10 | MP0004185_abnormal_adipocyte_glucose | 2.45206135 |
| 11 | MP0003646_muscle_fatigue | 2.36204163 |
| 12 | MP0009840_abnormal_foam_cell | 2.25445259 |
| 13 | MP0003303_peritoneal_inflammation | 2.01347719 |
| 14 | MP0005666_abnormal_adipose_tissue | 1.95522777 |
| 15 | MP0002396_abnormal_hematopoietic_system | 1.92618435 |
| 16 | MP0008995_early_reproductive_senescence | 1.81346637 |
| 17 | MP0003329_amyloid_beta_deposits | 1.79547240 |
| 18 | MP0004036_abnormal_muscle_relaxation | 1.78947572 |
| 19 | MP0001545_abnormal_hematopoietic_system | 1.75336172 |
| 20 | MP0005397_hematopoietic_system_phenotyp | 1.75336172 |
| 21 | MP0005464_abnormal_platelet_physiology | 1.72122384 |
| 22 | MP0005330_cardiomyopathy | 1.69629548 |
| 23 | MP0002822_catalepsy | 1.68934170 |
| 24 | MP0000003_abnormal_adipose_tissue | 1.63224639 |
| 25 | MP0000747_muscle_weakness | 1.58422088 |
| 26 | MP0000759_abnormal_skeletal_muscle | 1.55791393 |
| 27 | MP0002419_abnormal_innate_immunity | 1.55017080 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.54995962 |
| 29 | MP0005375_adipose_tissue_phenotype | 1.54887555 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.54623563 |
| 31 | MP0004087_abnormal_muscle_fiber | 1.53392259 |
| 32 | MP0004233_abnormal_muscle_weight | 1.51627976 |
| 33 | MP0000678_abnormal_parathyroid_gland | 1.49756942 |
| 34 | MP0001800_abnormal_humoral_immune | 1.49306409 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.48702434 |
| 36 | MP0000749_muscle_degeneration | 1.48689299 |
| 37 | MP0002398_abnormal_bone_marrow | 1.45621868 |
| 38 | MP0002106_abnormal_muscle_physiology | 1.43127806 |
| 39 | MP0003724_increased_susceptibility_to | 1.41631910 |
| 40 | MP0001873_stomach_inflammation | 1.41440199 |
| 41 | MP0005670_abnormal_white_adipose | 1.40322952 |
| 42 | MP0005025_abnormal_response_to | 1.40130854 |
| 43 | MP0002269_muscular_atrophy | 1.39847395 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.38922946 |
| 45 | MP0005000_abnormal_immune_tolerance | 1.38147903 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.36933497 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.36084341 |
| 48 | MP0001819_abnormal_immune_cell | 1.33442390 |
| 49 | MP0002132_abnormal_respiratory_system | 1.32669053 |
| 50 | MP0002723_abnormal_immune_serum | 1.32281644 |
| 51 | MP0000681_abnormal_thyroid_gland | 1.29519928 |
| 52 | MP0002332_abnormal_exercise_endurance | 1.28866002 |
| 53 | MP0005360_urolithiasis | 1.28780712 |
| 54 | MP0001835_abnormal_antigen_presentation | 1.27808184 |
| 55 | MP0004145_abnormal_muscle_electrophysio | 1.26396284 |
| 56 | MP0002452_abnormal_antigen_presenting | 1.25695317 |
| 57 | MP0002722_abnormal_immune_system | 1.21076218 |
| 58 | MP0004510_myositis | 1.19388845 |
| 59 | MP0002249_abnormal_larynx_morphology | 1.18093462 |
| 60 | MP0000716_abnormal_immune_system | 1.17480407 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.16428058 |
| 62 | MP0002971_abnormal_brown_adipose | 1.15570369 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 1.13904363 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 1.13671731 |
| 65 | MP0010630_abnormal_cardiac_muscle | 1.12997940 |
| 66 | MP0000685_abnormal_immune_system | 1.10835133 |
| 67 | MP0002405_respiratory_system_inflammati | 1.10750276 |
| 68 | MP0001790_abnormal_immune_system | 1.09557028 |
| 69 | MP0005387_immune_system_phenotype | 1.09557028 |
| 70 | MP0002429_abnormal_blood_cell | 1.08782242 |
| 71 | MP0004947_skin_inflammation | 1.08685532 |
| 72 | MP0002009_preneoplasia | 1.08427967 |
| 73 | MP0005369_muscle_phenotype | 1.07954314 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 1.05239719 |
| 75 | MP0005499_abnormal_olfactory_system | 1.05118041 |
| 76 | MP0005394_taste/olfaction_phenotype | 1.05118041 |
| 77 | MP0000604_amyloidosis | 1.04362705 |
| 78 | MP0008789_abnormal_olfactory_epithelium | 1.03066610 |
| 79 | MP0004130_abnormal_muscle_cell | 1.00009949 |
| 80 | MP0001533_abnormal_skeleton_physiology | 0.99625453 |
| 81 | MP0002970_abnormal_white_adipose | 0.96071078 |
| 82 | MP0008961_abnormal_basal_metabolism | 0.94538677 |
| 83 | MP0006138_congestive_heart_failure | 0.93944020 |
| 84 | MP0000750_abnormal_muscle_regeneration | 0.92191362 |
| 85 | MP0005076_abnormal_cell_differentiation | 0.91169856 |
| 86 | MP0004084_abnormal_cardiac_muscle | 0.90275447 |
| 87 | MP0000733_abnormal_muscle_development | 0.88484702 |
| 88 | MP0008874_decreased_physiological_sensi | 0.86148789 |
| 89 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85923505 |
| 90 | MP0003786_premature_aging | 0.85667043 |
| 91 | MP0003300_gastrointestinal_ulcer | 0.84465200 |
| 92 | MP0000858_altered_metastatic_potential | 0.82497170 |
| 93 | MP0005535_abnormal_body_temperature | 0.81709089 |
| 94 | MP0001851_eye_inflammation | 0.80040677 |
| 95 | MP0002127_abnormal_cardiovascular_syste | 0.79585871 |
| 96 | MP0003828_pulmonary_edema | 0.76896436 |
| 97 | MP0002139_abnormal_hepatobiliary_system | 0.73575344 |
| 98 | MP0004381_abnormal_hair_follicle | 0.73102818 |
| 99 | MP0000013_abnormal_adipose_tissue | 0.70946262 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.70253035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.55765849 |
| 2 | Myopathic facies (HP:0002058) | 4.05812441 |
| 3 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.49791283 |
| 4 | Myoglobinuria (HP:0002913) | 3.44479203 |
| 5 | Ragged-red muscle fibers (HP:0003200) | 3.41043288 |
| 6 | Rhabdomyolysis (HP:0003201) | 3.34512618 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 3.25751425 |
| 8 | Asymmetric septal hypertrophy (HP:0001670) | 3.23554671 |
| 9 | Colitis (HP:0002583) | 3.19147859 |
| 10 | Nemaline bodies (HP:0003798) | 3.06261032 |
| 11 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.04021092 |
| 12 | Fatigue (HP:0012378) | 3.00807854 |
| 13 | Muscle stiffness (HP:0003552) | 2.85343245 |
| 14 | Recurrent abscess formation (HP:0002722) | 2.76124245 |
| 15 | Increased connective tissue (HP:0009025) | 2.75388866 |
| 16 | Eczematoid dermatitis (HP:0000976) | 2.74248620 |
| 17 | Progressive muscle weakness (HP:0003323) | 2.72937733 |
| 18 | Gastrointestinal inflammation (HP:0004386) | 2.72740486 |
| 19 | Ulnar deviation of the wrist (HP:0003049) | 2.68711848 |
| 20 | Abnormal gallbladder physiology (HP:0012438) | 2.62041791 |
| 21 | Cholecystitis (HP:0001082) | 2.62041791 |
| 22 | Distal lower limb muscle weakness (HP:0009053) | 2.57283900 |
| 23 | Distal lower limb amyotrophy (HP:0008944) | 2.45742265 |
| 24 | Exercise-induced muscle cramps (HP:0003710) | 2.43978068 |
| 25 | EMG: myopathic abnormalities (HP:0003458) | 2.43524054 |
| 26 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.41172194 |
| 27 | Recurrent bacterial skin infections (HP:0005406) | 2.40937778 |
| 28 | EMG: neuropathic changes (HP:0003445) | 2.39331819 |
| 29 | Type 1 muscle fiber predominance (HP:0003803) | 2.38048243 |
| 30 | Inflammation of the large intestine (HP:0002037) | 2.35285074 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.31581721 |
| 32 | Supranuclear gaze palsy (HP:0000605) | 2.28121246 |
| 33 | Panhypogammaglobulinemia (HP:0003139) | 2.27979280 |
| 34 | Difficulty climbing stairs (HP:0003551) | 2.27955987 |
| 35 | Myositis (HP:0100614) | 2.27334334 |
| 36 | Increased variability in muscle fiber diameter (HP:0003557) | 2.25288447 |
| 37 | Acute hepatic failure (HP:0006554) | 2.21140873 |
| 38 | Muscle fiber splitting (HP:0003555) | 2.20998093 |
| 39 | Cellulitis (HP:0100658) | 2.19655977 |
| 40 | Difficulty running (HP:0009046) | 2.16159789 |
| 41 | Sudden death (HP:0001699) | 2.14626745 |
| 42 | Abnormality of lateral ventricle (HP:0030047) | 2.14277989 |
| 43 | Thoracic kyphosis (HP:0002942) | 2.12436905 |
| 44 | Cholelithiasis (HP:0001081) | 2.12061452 |
| 45 | Lymphangioma (HP:0100764) | 2.12014292 |
| 46 | Chest pain (HP:0100749) | 2.11417279 |
| 47 | Slow saccadic eye movements (HP:0000514) | 2.11072987 |
| 48 | Abnormality of the thoracic spine (HP:0100711) | 2.09978663 |
| 49 | Progressive microcephaly (HP:0000253) | 2.08969680 |
| 50 | Granulocytopenia (HP:0001913) | 2.08878984 |
| 51 | Interstitial pulmonary disease (HP:0006530) | 2.08691550 |
| 52 | Agammaglobulinemia (HP:0004432) | 2.06737004 |
| 53 | Recurrent fungal infections (HP:0002841) | 2.03092378 |
| 54 | Purpura (HP:0000979) | 2.01347770 |
| 55 | Abnormality of the fingertips (HP:0001211) | 2.00819359 |
| 56 | Bulbar palsy (HP:0001283) | 2.00478781 |
| 57 | Hypertensive crisis (HP:0100735) | 2.00210049 |
| 58 | Easy fatigability (HP:0003388) | 1.98954218 |
| 59 | Papilledema (HP:0001085) | 1.97894549 |
| 60 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.97880477 |
| 61 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.97880477 |
| 62 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.97880477 |
| 63 | Dysostosis multiplex (HP:0000943) | 1.97580984 |
| 64 | Prolonged bleeding time (HP:0003010) | 1.97422199 |
| 65 | Broad distal phalanx of finger (HP:0009836) | 1.97147329 |
| 66 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.96883159 |
| 67 | Dicarboxylic aciduria (HP:0003215) | 1.96883159 |
| 68 | Loss of speech (HP:0002371) | 1.95756700 |
| 69 | Reticulocytosis (HP:0001923) | 1.94973942 |
| 70 | Mediastinal lymphadenopathy (HP:0100721) | 1.93827311 |
| 71 | Epistaxis (HP:0000421) | 1.93512366 |
| 72 | Hyporeflexia of lower limbs (HP:0002600) | 1.93143700 |
| 73 | Abnormality of macrophages (HP:0004311) | 1.92087156 |
| 74 | Hemorrhage of the eye (HP:0011885) | 1.89573578 |
| 75 | Petechiae (HP:0000967) | 1.89150757 |
| 76 | Spontaneous hematomas (HP:0007420) | 1.88120980 |
| 77 | Gastrointestinal stroma tumor (HP:0100723) | 1.86892368 |
| 78 | Mucopolysacchariduria (HP:0008155) | 1.84743167 |
| 79 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.84743167 |
| 80 | Seborrheic dermatitis (HP:0001051) | 1.84386258 |
| 81 | Restrictive lung disease (HP:0002091) | 1.84196161 |
| 82 | Growth hormone excess (HP:0000845) | 1.83994646 |
| 83 | Ankle clonus (HP:0011448) | 1.82671509 |
| 84 | Neck muscle weakness (HP:0000467) | 1.80669791 |
| 85 | Hepatosplenomegaly (HP:0001433) | 1.79943443 |
| 86 | Increased serum ferritin (HP:0003281) | 1.78929649 |
| 87 | Increased IgE level (HP:0003212) | 1.78282731 |
| 88 | Abnormal gallbladder morphology (HP:0012437) | 1.77850635 |
| 89 | Meningitis (HP:0001287) | 1.77341608 |
| 90 | Gastrointestinal infarctions (HP:0005244) | 1.76435463 |
| 91 | Ventricular tachycardia (HP:0004756) | 1.76333891 |
| 92 | Recurrent viral infections (HP:0004429) | 1.76277541 |
| 93 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.76085128 |
| 94 | Bundle branch block (HP:0011710) | 1.76078112 |
| 95 | Neuronal loss in central nervous system (HP:0002529) | 1.75125662 |
| 96 | Chronic obstructive pulmonary disease (HP:0006510) | 1.74946756 |
| 97 | Obstructive lung disease (HP:0006536) | 1.74946756 |
| 98 | Round ear (HP:0100830) | 1.73137629 |
| 99 | Cerebral palsy (HP:0100021) | 1.72200410 |
| 100 | Athetosis (HP:0002305) | 1.71863025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.55248171 |
| 2 | TRIB3 | 3.34172188 |
| 3 | MAP4K1 | 2.87271823 |
| 4 | PRPF4B | 2.81738117 |
| 5 | MAP2K3 | 2.45805116 |
| 6 | SIK1 | 2.28107073 |
| 7 | TNK2 | 2.14734041 |
| 8 | TYK2 | 2.00438972 |
| 9 | TTN | 1.89462206 |
| 10 | TAOK3 | 1.85698113 |
| 11 | IRAK3 | 1.85277505 |
| 12 | SIK2 | 1.82328956 |
| 13 | EPHB1 | 1.80515170 |
| 14 | SMG1 | 1.72066038 |
| 15 | ICK | 1.68524465 |
| 16 | GRK6 | 1.67835140 |
| 17 | MAP3K11 | 1.67485210 |
| 18 | TESK2 | 1.64830471 |
| 19 | TESK1 | 1.64628624 |
| 20 | OBSCN | 1.64488851 |
| 21 | BCKDK | 1.52746298 |
| 22 | TBK1 | 1.51159640 |
| 23 | MARK2 | 1.48961782 |
| 24 | PHKG1 | 1.45744530 |
| 25 | PHKG2 | 1.45744530 |
| 26 | ZAP70 | 1.44145365 |
| 27 | PRKD3 | 1.42171763 |
| 28 | SIK3 | 1.41690944 |
| 29 | MAP3K7 | 1.38726603 |
| 30 | MAP4K2 | 1.34804291 |
| 31 | RIPK4 | 1.24804242 |
| 32 | NME2 | 1.24118240 |
| 33 | BLK | 1.20531847 |
| 34 | PRKD2 | 1.19689437 |
| 35 | MAP3K6 | 1.18300082 |
| 36 | FGFR4 | 1.17643364 |
| 37 | CDC42BPA | 1.15281208 |
| 38 | HIPK2 | 1.14884760 |
| 39 | JAK3 | 1.12212928 |
| 40 | MAPK12 | 1.10060099 |
| 41 | MAPK11 | 1.08511602 |
| 42 | PKN2 | 1.05584109 |
| 43 | BTK | 1.05270798 |
| 44 | MAP3K13 | 1.05089099 |
| 45 | EEF2K | 1.03193204 |
| 46 | FES | 1.02471175 |
| 47 | TAOK2 | 0.99156550 |
| 48 | ARAF | 0.98056269 |
| 49 | MAP3K3 | 0.97996215 |
| 50 | CDK12 | 0.94967048 |
| 51 | PTK6 | 0.93596254 |
| 52 | CSF1R | 0.90481474 |
| 53 | RIPK1 | 0.87956047 |
| 54 | JAK1 | 0.83527085 |
| 55 | IKBKE | 0.82964540 |
| 56 | MAP3K14 | 0.82503686 |
| 57 | KDR | 0.81969273 |
| 58 | CDK4 | 0.81056690 |
| 59 | MAPK7 | 0.80384868 |
| 60 | CAMKK1 | 0.79805284 |
| 61 | DYRK1B | 0.78702662 |
| 62 | CDK9 | 0.77975901 |
| 63 | SYK | 0.74426260 |
| 64 | IRAK4 | 0.73819323 |
| 65 | MAP3K1 | 0.72743305 |
| 66 | PIM2 | 0.71246504 |
| 67 | HCK | 0.70514101 |
| 68 | MARK3 | 0.68643837 |
| 69 | MAP3K10 | 0.66454797 |
| 70 | PDK1 | 0.65527628 |
| 71 | PDPK1 | 0.64966321 |
| 72 | TAOK1 | 0.61593816 |
| 73 | STK38 | 0.61441029 |
| 74 | KIT | 0.60312367 |
| 75 | VRK2 | 0.59966296 |
| 76 | NME1 | 0.59488821 |
| 77 | EPHA3 | 0.58765527 |
| 78 | RPS6KL1 | 0.58646404 |
| 79 | RPS6KC1 | 0.58646404 |
| 80 | MTOR | 0.57782466 |
| 81 | MAP2K2 | 0.55568025 |
| 82 | ITK | 0.55059944 |
| 83 | PINK1 | 0.52658045 |
| 84 | BMX | 0.51206012 |
| 85 | PRKD1 | 0.48762226 |
| 86 | RPS6KA2 | 0.47115922 |
| 87 | JAK2 | 0.46947686 |
| 88 | CDK7 | 0.44348793 |
| 89 | LCK | 0.42760734 |
| 90 | MAP2K6 | 0.42144328 |
| 91 | LYN | 0.41255778 |
| 92 | IRAK2 | 0.40582020 |
| 93 | SCYL2 | 0.40406824 |
| 94 | RET | 0.39829452 |
| 95 | MAPKAPK2 | 0.39718110 |
| 96 | PRKAA1 | 0.39647201 |
| 97 | RPS6KA6 | 0.38583200 |
| 98 | MAP3K8 | 0.38388398 |
| 99 | KSR2 | 0.37646992 |
| 100 | LRRK2 | 0.37414328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.20192762 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.80738001 |
| 3 | Sulfur relay system_Homo sapiens_hsa04122 | 2.62744777 |
| 4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.29386157 |
| 5 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.28368444 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.22667796 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.15514389 |
| 8 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.05935506 |
| 9 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.04111817 |
| 10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.03798273 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 1.98094658 |
| 12 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.67583967 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67185988 |
| 14 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.56552049 |
| 15 | Carbon metabolism_Homo sapiens_hsa01200 | 1.56422124 |
| 16 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.54670126 |
| 17 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.49627788 |
| 18 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.42852128 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.39066723 |
| 20 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.35064034 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.33078147 |
| 22 | Lysine degradation_Homo sapiens_hsa00310 | 1.31605063 |
| 23 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.29261210 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28777009 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25039234 |
| 26 | Galactose metabolism_Homo sapiens_hsa00052 | 1.22153440 |
| 27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.18086527 |
| 28 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.16414806 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.14950127 |
| 30 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.12314525 |
| 31 | Insulin resistance_Homo sapiens_hsa04931 | 1.10770313 |
| 32 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.10642310 |
| 33 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.09025684 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.07509639 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05450798 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04289982 |
| 37 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.02725566 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99056765 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98137168 |
| 40 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.96435667 |
| 41 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.95056068 |
| 42 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.92926109 |
| 43 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.92845542 |
| 44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.92290814 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 0.91167710 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.90361668 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.87263738 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84641061 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 0.83273258 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83125430 |
| 51 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.82970514 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82955159 |
| 53 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82368347 |
| 54 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82285778 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.82222897 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81282830 |
| 57 | Tuberculosis_Homo sapiens_hsa05152 | 0.79723304 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79478346 |
| 59 | Endocytosis_Homo sapiens_hsa04144 | 0.79307002 |
| 60 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79179620 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78657988 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77367441 |
| 63 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75521607 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75482829 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74640910 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74271688 |
| 67 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.73306233 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.71804731 |
| 69 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.68878019 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68180464 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66762258 |
| 72 | Allograft rejection_Homo sapiens_hsa05330 | 0.66072457 |
| 73 | Measles_Homo sapiens_hsa05162 | 0.64654870 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.62876815 |
| 75 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.62270473 |
| 76 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.62107878 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61558748 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60196761 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.59772237 |
| 80 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57250197 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56225991 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55485572 |
| 83 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.53816448 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53678458 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53071234 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52884306 |
| 87 | Apoptosis_Homo sapiens_hsa04210 | 0.52448127 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51241349 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50201534 |
| 90 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.49129931 |
| 91 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.49053243 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.47626545 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.46220157 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43687112 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43385085 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.41213145 |
| 97 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.40318140 |
| 98 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.40088768 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37935676 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.36710232 |

